“…The largest was a population-based study involving 456,002 individuals from the United Kingdom at least 4 weeks after COVID-19, where arthralgia was present in 2% to 3% of the patients [72]. In 10 other studies, including 9756 patients overall, a prevalence of joint pain ranging from 10% to 19% was described [35,38,40,41,45,46,51,58,69,73], while 11 studies assessing post-COVID-19 symptoms in 28,303 patients showed higher figures, between 20% and 29% [28,34,42,43,47,49,64,66,71,75,76]. Most of these patients were contributed by Wang et al [71].…”